Ideas to action: independent research for global prosperity
9:30—10:45 AM ET / 2:30-3:45 PM GMT
The Road to “Gavi 6.0”: A New Strategy for a Changing World
February 06, 2024
Join CGD for a virtual panel discussion, building on new research and analyses, to examine how Gavi can adopt a new playbook to maximize impact and remain fit-for-purpose in an evolving global landscape.
The 2024-2025 Replenishment Traffic Jam: Are We Headed for a Pileup?
February 08, 2024
With several replenishment campaigns set for 2024-2025, a fundraising pileup is on the horizon. Close to a dozen major development funds—including the World Bank’s International Development Association (IDA), thematic funds like Gavi, and new entities like the Loss and Damage Fund—could aim to raise...
Gavi Needs a New Playbook to Deliver Impact in a Changing World
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...
A New Playbook for Gavi: Advancing Equitable and Sustainable Immunization in an Evolving Global Landscape
January 30, 2024
For nearly 25 years, Gavi has delivered impact and value for money and remained one of the most successful global health initiatives. Gavi’s success has been driven by its use of three primary levers: (1) accelerating new vaccine introductions, (2) increasing equitable immunization coverage, and (3)...
It’s Time to Evolve Gavi’s Eligibility and Transition Model
December 14, 2023
Harsh fiscal prospects and broader shifts in the health landscape are creating challenges for Gavi’s approach to country eligibility and transition. To date, Gavi’s income-based eligibility model has functioned well during periods of sustained growth in low- and middle-income countries and has helpe...
Projections of Eligibility and Transition Trajectories up to 2040: Implications for Gavi’s Next Strategic Period and Beyond
December 14, 2023
The prevailing fiscal outlook alongside broader shifts in the health landscape have important implications for countries’ eligibility for support from Gavi, the Vaccine Alliance. Current projections are similar to pre-COVID estimates, but the cohort of transitioning countries face more challenging ...
Deciding the Fate of Billions: What’s Next for Gavi’s Unspent COVAX Funds?
December 04, 2023
In the aftermath of the COVID-19 pandemic, Gavi faces an unprecedented situation. Billions of dollars that it raised back in 2022 for COVAX—the global effort to provide COVID-19 vaccines to lower-income countries—remain unspent. These resources are substantial, exceeding the entire annual budget of ...
Gavi 6.0: A New Era for Global Immunization
December 01, 2023
When Gavi’s board meets in Accra, Ghana, next week, advancing discussions on a new five-year strategic period, known as “Gavi 6.0,” will be a top agenda item. But conversations about Gavi’s future direction are also taking place against the backdrop of a leadership transition and a rapidly changing ...
Accelerating Vaccine Manufacturing in Africa: Three Considerations for Gavi
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...
Gavi’s AMC for African Vaccine Manufacturing: Start With These Three Foundational Questions
August 16, 2023
Despite verbal nods to global cooperation, equity, and solidarity, the COVID-19 pandemic laid bare a brutal realpolitik: all countries will put their citizens first and vaccinate their own populations, before offering charitable leftovers beyond their own borders. Sub-Saharan Africa, more than any o...